Bupivacaine
( DrugBank: Bupivacaine / KEGG DRUG: Bupivacaine hydrochloride, Bupivacaine )
3 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 70 | Spinal stenosis | 4 |
| 168 | Ehlers-Danlos syndrome | 1 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 226 | Interstitial cystitis with Hunners ulcer | 2 |
70. Spinal stenosis
Clinical trials : 127 / Drugs : 178 - (DrugBank : 67) / Drug target genes : 87 - Drug target pathways : 99
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
168. Ehlers-Danlos syndrome
Clinical trials : 16 / Drugs : 22 - (DrugBank : 10) / Drug target genes : 11 - Drug target pathways : 103
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
226. Interstitial cystitis with Hunners ulcer
Clinical trials : 163 / Drugs : 158 - (DrugBank : 58) / Drug target genes : 79 - Drug target pathways : 142
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|